Susquehanna International Group, LLP Immunocore Holdings PLC Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Susquehanna International Group, LLP holds 22,800 shares of IMCR stock, worth $729,828. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,800
Previous 7,600
200.0%
Holding current value
$729,828
Previous $224,000
201.79%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IMCR
# of Institutions
128Shares Held
44.6MCall Options Held
219KPut Options Held
125K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$226 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$196 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$156 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$85.7 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$74.3 Million0.82% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.41B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...